CompanyCore
UK company intelligence
Company profile report
Prepared 22 July 2026
PANDEIA THERAPEUTICS LIMITED
11463856 · ltd · incorporated 2018-07-13
1. Company facts
- Status
- active
- Lifecycle
- 💤 Zombie — Technically active but dormant or stalled — minimal activity.
- Jurisdiction
- england-wales
- Registered office
- The Cambridge Partnership The Dorothy Hodgkin Bldg Babraham Research Campus, Babraham, Cambridge, CB22 3FH, England
- SIC codes
- 72110 — Research and experimental development on biotechnology
- Accounts next due
- 2026-09-30
- Confirmation statement next due
- 2027-07-10
2. Directors (1 active)
- RHODES, Jennifer
- director · appointed 2024-04-26 · born 4/1970 (age 56)
3. Shareholders (1 active)
- Acadia Pharmaceuticals Inc.
- 75-100% shares
4. Group structure
Acadia Pharmaceuticals Inc. is the ultimate parent — holding 75%+ shares. This company sits inside their group.
- Acadia Pharmaceuticals Inc.
- Corporate parent · 75-100%
Headline verdict
- Opportunity score
- 72/100 (Strong)
- Owner dependency
- high — 75/100
- Red flags
- 0 high · 0 medium · 0 low